Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Melanin is a normal production protecting skin from environment-causing damage. Plants produce some agents in response to their environment. These agents could be applied in cosmetic production. Some Chinese herbals have immunomodulatory activities and modulate the symptoms of several diseases. Melanogenesis represents a complex group of conditions that are thought to be mediated through a complex network of regulatory processes. Previously, some studies found that the extracts of
Astragalus membranaceus
(
PG2
) regulated immunity and supported hematopoiesis. Herein, we want to determine the molecular mechanisms by which
PG2
inhibits melanogenesis in B16F10 melanoma cells. The cellular melanin contents and expression of melanogenesis-related protein, including microphthalmia associated transcription factor (MITF) and
tyrosinase
were significantly reduced after
PG2
treatment. Moreover,
PG2
increased phosphorylation of ERK, without affecting phosphorylation of p38. These results suggested that
PG2
as a new target in reducing hyperpigmentation through the ERK signal pathway.
PG2
has potential for cosmetic usage in the future.
...
PMID:The Extracts of
Astragalus membranaceus
Inhibit Melanogenesis through the ERK Signaling Pathway. 2910 57